US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

57.420
+1.010+1.79%

Close Jul 22 16:00 ET

57.420
0.0000.00%

Post 17:08 ET

6.73BMarket Cap-10633P/E (TTM)

Cytokinetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5.91%-129.51M

-38.33%-414.33M

24.60%-74.04M

-14.48%-96.21M

-34.63%-121.81M

-356.10%-122.29M

-110.15%-299.52M

-119.48%-98.19M

-116.77%-84.04M

-206.74%-90.48M

Net income from continuing operations

-3.32%-135.64M

-35.30%-526.24M

0.35%-136.9M

9.06%-129.42M

-549.03%-128.64M

-46.78%-131.29M

-80.65%-388.96M

-349.39%-137.38M

-87.04%-142.31M

67.80%-19.82M

Operating gains losses

----

-98.75%35K

--0

--1K

-98.74%34K

--2.8M

--0

--107K

--0

Depreciation and amortization

26.14%2.33M

104.54%11.89M

282.09%6.34M

31.68%1.85M

31.84%1.86M

37.81%1.85M

155.45%5.81M

125.89%1.66M

204.76%1.41M

159.12%1.41M

Other non cash items

-28.88%7.89M

-56.95%24.83M

-209.01%-7.84M

-64.94%11.17M

9.43%10.41M

21.66%11.1M

78.10%57.68M

-24.91%7.19M

274.03%31.85M

22.96%9.51M

Change In working capital

-34.05%-25.7M

112.50%3.09M

166.50%44.88M

-87.38%1.48M

74.30%-24.1M

-147.35%-19.17M

-392.15%-24.7M

149.48%16.84M

-42.98%11.73M

-661.88%-93.77M

-Change in receivables

152.27%449K

-102.00%-1.14M

-43.36%1.22M

-371.65%-1.51M

-99.49%21K

-101.69%-859K

219.56%56.67M

104.20%2.15M

-115.61%-321K

125.21%4.08M

-Change in prepaid assets

-307.50%-6.63M

121.53%1.6M

458.44%8.53M

137.62%342K

14.51%-5.65M

-14.42%-1.63M

-0.45%-7.41M

-60.45%1.53M

83.95%-909K

19.94%-6.61M

-Change in payables and accrued expense

-0.08%-15.87M

-11.37%13.62M

213.77%39.84M

-55.25%5.39M

-468.35%-15.75M

-140.25%-15.86M

-4.64%15.37M

149.16%12.7M

16.20%12.04M

-135.43%-2.77M

-Change in other current liabilities

-342.06%-3.65M

-371.72%-10.99M

-1,106.41%-4.71M

-398.47%-2.74M

-85.22%-2.72M

63.28%-825K

-104.94%-2.33M

-94.28%468K

-93.36%917K

-109.59%-1.47M

-Change in other working capital

----

---87M

--0

----

Cash from discontinued investing activities

Operating cash flow

-5.91%-129.51M

-38.33%-414.33M

24.60%-74.04M

-14.48%-96.21M

-34.63%-121.81M

-356.10%-122.29M

-110.15%-299.52M

-119.48%-98.19M

-116.77%-84.04M

-206.74%-90.48M

Investing cash flow

Cash flow from continuing investing activities

-80.28%32.64M

191.27%239.25M

-378.34%-81.41M

124.98%73.04M

25.83%82.13M

357.47%165.5M

-77.38%-262.13M

-38.21%29.25M

-40.08%-292.37M

245.68%65.27M

Net PPE purchase and sale

--0

87.51%-1.42M

97.60%-77K

96.53%-220K

16.34%-717K

57.32%-402K

76.81%-11.34M

81.95%-3.21M

59.68%-6.33M

90.25%-857K

Net investment purchase and sale

-80.32%32.64M

195.96%240.67M

-350.61%-81.33M

125.61%73.26M

25.29%82.85M

361.93%165.9M

-153.58%-250.8M

-50.14%32.45M

-48.19%-286.04M

138.95%66.13M

Cash from discontinued investing activities

Investing cash flow

-80.28%32.64M

191.27%239.25M

-378.34%-81.41M

124.98%73.04M

25.83%82.13M

357.47%165.5M

-77.38%-262.13M

-38.21%29.25M

-40.08%-292.37M

245.68%65.27M

Financing cash flow

Cash flow from continuing financing activities

1,546.16%103.79M

-57.12%221.32M

464.83%168.8M

-86.06%54.22M

60.28%5.48M

-107.65%-7.18M

61.31%516.17M

53.21%29.89M

29.29%389.02M

7.59%3.42M

Net issuance payments of debt

-350.24%-932K

-100.26%-858K

-111.43%-222K

-100.06%-217K

20.60%-212K

99.57%-207K

--334.66M

---105K

--382.83M

---267K

Net common stock issuance

--93.64M

--164.23M

--162.92M

----

--0

----

Proceeds from stock option exercised by employees

732.59%29.53M

5.22%18.46M

69.57%6.1M

-49.51%3.12M

54.41%5.69M

-12.96%3.55M

41.70%17.54M

-59.16%3.6M

55.06%6.19M

16.00%3.68M

Net other financing activities

-75.42%-18.45M

-75.92%39.48M

--0

--50M

--0

-107.64%-10.52M

3,785.37%163.96M

--26.39M

--0

Cash from discontinued financing activities

Financing cash flow

1,546.16%103.79M

-57.12%221.32M

464.83%168.8M

-86.06%54.22M

60.28%5.48M

-107.65%-7.18M

61.31%516.17M

53.21%29.89M

29.29%389.02M

7.59%3.42M

Net cash flow

Beginning cash position

68.79%113.4M

-40.37%67.18M

-5.81%100.07M

-26.29%69.01M

-10.58%103.22M

-40.37%67.18M

35.77%112.67M

17.31%106.24M

152.01%93.63M

158.83%115.42M

Current changes in cash

-80.78%6.93M

201.66%46.24M

134.19%13.35M

146.32%31.05M

-56.95%-34.2M

1,207.47%36.03M

-253.24%-45.48M

-276.69%-39.06M

-76.39%12.61M

-192.89%-21.79M

Effect of exchange rate changes

--27K

---20K

----

--0

----

End cash Position

16.60%120.35M

68.79%113.4M

-5.81%100.07M

-26.29%69.01M

-10.58%103.22M

-40.37%67.18M

17.31%106.24M

152.01%93.63M

Free cash flow

-5.56%-129.51M

-33.75%-415.75M

26.91%-74.11M

-6.70%-96.43M

-34.15%-122.52M

-342.07%-122.69M

-62.41%-310.85M

-62.26%-101.4M

-65.91%-90.37M

-138.54%-91.33M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5.91%-129.51M	-38.33%-414.33M	24.60%-74.04M	-14.48%-96.21M	-34.63%-121.81M	-356.10%-122.29M	-110.15%-299.52M	-119.48%-98.19M	-116.77%-84.04M	-206.74%-90.48M
Net income from continuing operations	-3.32%-135.64M	-35.30%-526.24M	0.35%-136.9M	9.06%-129.42M	-549.03%-128.64M	-46.78%-131.29M	-80.65%-388.96M	-349.39%-137.38M	-87.04%-142.31M	67.80%-19.82M
Operating gains losses	----	-98.75%35K	--0	--0	--1K	-98.74%34K	--2.8M	--0	--107K	--0
Depreciation and amortization	26.14%2.33M	104.54%11.89M	282.09%6.34M	31.68%1.85M	31.84%1.86M	37.81%1.85M	155.45%5.81M	125.89%1.66M	204.76%1.41M	159.12%1.41M
Other non cash items	-28.88%7.89M	-56.95%24.83M	-209.01%-7.84M	-64.94%11.17M	9.43%10.41M	21.66%11.1M	78.10%57.68M	-24.91%7.19M	274.03%31.85M	22.96%9.51M
Change In working capital	-34.05%-25.7M	112.50%3.09M	166.50%44.88M	-87.38%1.48M	74.30%-24.1M	-147.35%-19.17M	-392.15%-24.7M	149.48%16.84M	-42.98%11.73M	-661.88%-93.77M
-Change in receivables	152.27%449K	-102.00%-1.14M	-43.36%1.22M	-371.65%-1.51M	-99.49%21K	-101.69%-859K	219.56%56.67M	104.20%2.15M	-115.61%-321K	125.21%4.08M
-Change in prepaid assets	-307.50%-6.63M	121.53%1.6M	458.44%8.53M	137.62%342K	14.51%-5.65M	-14.42%-1.63M	-0.45%-7.41M	-60.45%1.53M	83.95%-909K	19.94%-6.61M
-Change in payables and accrued expense	-0.08%-15.87M	-11.37%13.62M	213.77%39.84M	-55.25%5.39M	-468.35%-15.75M	-140.25%-15.86M	-4.64%15.37M	149.16%12.7M	16.20%12.04M	-135.43%-2.77M
-Change in other current liabilities	-342.06%-3.65M	-371.72%-10.99M	-1,106.41%-4.71M	-398.47%-2.74M	-85.22%-2.72M	63.28%-825K	-104.94%-2.33M	-94.28%468K	-93.36%917K	-109.59%-1.47M
-Change in other working capital	----	----	----	----	----	----	---87M	--0	--0	----
Cash from discontinued investing activities
Operating cash flow	-5.91%-129.51M	-38.33%-414.33M	24.60%-74.04M	-14.48%-96.21M	-34.63%-121.81M	-356.10%-122.29M	-110.15%-299.52M	-119.48%-98.19M	-116.77%-84.04M	-206.74%-90.48M
Investing cash flow
Cash flow from continuing investing activities	-80.28%32.64M	191.27%239.25M	-378.34%-81.41M	124.98%73.04M	25.83%82.13M	357.47%165.5M	-77.38%-262.13M	-38.21%29.25M	-40.08%-292.37M	245.68%65.27M
Net PPE purchase and sale	--0	87.51%-1.42M	97.60%-77K	96.53%-220K	16.34%-717K	57.32%-402K	76.81%-11.34M	81.95%-3.21M	59.68%-6.33M	90.25%-857K
Net investment purchase and sale	-80.32%32.64M	195.96%240.67M	-350.61%-81.33M	125.61%73.26M	25.29%82.85M	361.93%165.9M	-153.58%-250.8M	-50.14%32.45M	-48.19%-286.04M	138.95%66.13M
Cash from discontinued investing activities
Investing cash flow	-80.28%32.64M	191.27%239.25M	-378.34%-81.41M	124.98%73.04M	25.83%82.13M	357.47%165.5M	-77.38%-262.13M	-38.21%29.25M	-40.08%-292.37M	245.68%65.27M
Financing cash flow
Cash flow from continuing financing activities	1,546.16%103.79M	-57.12%221.32M	464.83%168.8M	-86.06%54.22M	60.28%5.48M	-107.65%-7.18M	61.31%516.17M	53.21%29.89M	29.29%389.02M	7.59%3.42M
Net issuance payments of debt	-350.24%-932K	-100.26%-858K	-111.43%-222K	-100.06%-217K	20.60%-212K	99.57%-207K	--334.66M	---105K	--382.83M	---267K
Net common stock issuance	--93.64M	--164.23M	--162.92M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	732.59%29.53M	5.22%18.46M	69.57%6.1M	-49.51%3.12M	54.41%5.69M	-12.96%3.55M	41.70%17.54M	-59.16%3.6M	55.06%6.19M	16.00%3.68M
Net other financing activities	-75.42%-18.45M	-75.92%39.48M	--0	--50M	--0	-107.64%-10.52M	3,785.37%163.96M	--26.39M	--0	--0
Cash from discontinued financing activities
Financing cash flow	1,546.16%103.79M	-57.12%221.32M	464.83%168.8M	-86.06%54.22M	60.28%5.48M	-107.65%-7.18M	61.31%516.17M	53.21%29.89M	29.29%389.02M	7.59%3.42M
Net cash flow
Beginning cash position	68.79%113.4M	-40.37%67.18M	-5.81%100.07M	-26.29%69.01M	-10.58%103.22M	-40.37%67.18M	35.77%112.67M	17.31%106.24M	152.01%93.63M	158.83%115.42M
Current changes in cash	-80.78%6.93M	201.66%46.24M	134.19%13.35M	146.32%31.05M	-56.95%-34.2M	1,207.47%36.03M	-253.24%-45.48M	-276.69%-39.06M	-76.39%12.61M	-192.89%-21.79M
Effect of exchange rate changes	--27K	---20K	----	----	----	--0	--0	----	----	----
End cash Position	16.60%120.35M	68.79%113.4M	68.79%113.4M	-5.81%100.07M	-26.29%69.01M	-10.58%103.22M	-40.37%67.18M	-40.37%67.18M	17.31%106.24M	152.01%93.63M
Free cash flow	-5.56%-129.51M	-33.75%-415.75M	26.91%-74.11M	-6.70%-96.43M	-34.15%-122.52M	-342.07%-122.69M	-62.41%-310.85M	-62.26%-101.4M	-65.91%-90.37M	-138.54%-91.33M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall